Linda Reinstein, co-founder and president of the ADAO, an advocacy group, said the asbestos industry had argued for years that importation and exposure to asbestos have been gradually decreasing, but the new report shows that simply isn’t accurate.

According to the 2012 United State Geological Survey of mineral commodities,  U.S. industries consumed 1,100 metric tons of asbestos from January through July 2011, compared to 820 metric tons during the same period in 2010. The difference represents a 34 percent increase in consumption, Reinstein said.

The U.S. Geological Survey report estimated that roofing felt materials account for about 60 percent of U.S. consumption of asbestos. The chlorine manufacturing industry, which utilizes asbestos diaphragms in the manufacturing of industrial chemicals, accounted for about 30 percent of asbestos consumption, the report said. The United States still has asbestos diaphragm cell plants.

The use of asbestos creates an occupational hazard of asbestos exposure.  Asbestos exposure in the chlorine industry arises form the transport and storage of sacks of raw asbestos. Cutting open and empty sacks of asbestos and transferring asbestos into slurry mixing tanks and handling empty bags can cause additional exposures, according to testimony presented by environmental consultant Barry Castlemen to a U.S. Senate committee. The handling and storage of asbestos diaphragms presents another possible source of asbestos exposure, he said.

More than 30 years ago, the International Agency for Research on Cancer declared asbestos a human carcinogen, yet workplace exposure continues throughout the United States.

Reinstein called on Congress and the president to prohibit the importation of raw asbestos and asbestos-containing products. “I have lost my husband, Alan, to mesothelioma, a disease caused by asbestos exposure,” Reinstein said in a prepared statement. “Nothing can bring him or the hundreds of thousands of other victims back to life, but we can begin by aggressively preventing exposure thus eliminating deadly diseases.”

Approximately 3,000 people in the U.S. are diagnosed with mesothelioma each year. Most are older workers, retired workers and veterans who had workplace exposure to asbestos. Most people diagnosed with mesothelioma do not notice any symptoms of the disease for 20 years to 40 years after exposure.

For more information about mesothelioma, click here.

The All-Party Parliamentary Group on Occupational Safety and Health, an interest group, warned that 75 percent of schools  in Great Britain are exposing children, teachers and other staff to asbestos. Ministers of Parliament are calling upon the government to introduce a program to remove all asbestos from schools.

According to a Feb. 1 article in The Telegraph newspaper, more than 140 teachers have died from mesothelioma within the past 10 years. Asbestos fibers, when inhaled or ingested, can penetrate deep into the lung or abdominal cavity, lodging there and causing inflammation, scarring and eventually cancer.

The report by the All-Party Parliamentary Group of Occupational Safety and Health recommended annual updates for parents, teachers and staff about the presence of asbestos in schools.

Jim Sheridan, a Minister of Parliament and chairman of the group, said that urgent action is needed to prevent more students, teachers and school staff from being exposed to toxic asbestos dust. A mineral fiber, asbestos was widely used in building materials and insulation from the 1950s to mid-1980s in the United Kingdom.

Sheridan said that the British Department of Education’s best estimate was that about 75 percent of schools contained asbestos. Sheridan said Great Britain needed far greater awareness of the risk of asbestos.

According to the Health and Safety Executive, a British government agency that protects workers, asbestos is the single greatest cause of work-related deaths in the United Kingdom with approximately 4,000 people dying annually. In the U.S., approximately 3,000 people are diagnosed each year with mesothelioma as a result of asbestos exposure.

According to worker health data published by the National Institute of Occupational Safety and Health, a U.S. government agency, the occupations with the highest proportionate malignant mesothelioma mortality rates are plumbers, pipefitters, electricians and elementary school teachers. Most teachers and other workers who develop mesothelioma show symptoms of the disease 20 years to 40 years after exposure.

For more information about mesothelioma, click here.

An expert panel of the National Academy of Sciences recommended this week that a better understanding is needed of the risks of adverse health and environmental effects posed by nanomaterials in light of their rapidly expanding production and use in society. Materials that behave in unconventional ways because of their size may produce unanticipated health effects, the panel said. The concern was supported by research in the 1990s that showed that inhaled fine particles have the potential to cause more serious health effects than shown in studies of larger particles.

Nanomaterials share certain characteristics with asbestos fibers, raising concerns that they may increase risks of respiratory diseases such as lung cancer and mesothelioma, a cancer of the lining of the lung and abdomen. Approximately 3,000 people a year in the U.S. die of mesothelioma due to past exposure to asbestos. A heat resistant mineral fiber, asbestos was used in thousands of products for decades before its use was restricted due to its cancer-causing properties. The symptoms of asbestos-related disease typically appear decades after exposure.

Both asbestos and nanomaterials have fiber-like characteristics in their thin, elongated shape. They are so small that people may unknowingly inhale them, causing the fibers to penetrate deep into the lung and lodge there, causing inflammation.  Nanomaterials are being used in consumer products so people could  inhale or ingest them.

A 2009 article by French researchers in the journal Particle and Fibre Toxicology noted that studies of carbon nanotubes have shown  adverse effects similar to those observed with asbestos fibers and two recent studies by Japanese researchers showed the occurrence of malignant mesothelioma in mice and rats exposed to carbon nanotubes.

The diverse properties of nanomaterials make them challenging for researchers to assess the risks, the expert panel said. The toxic effects of nanomaterials will likely vary depending on the base materials of which they’re made.

For more information about mesothelioma and asbestos disease, click here.

In the new study published in January issue of the journal Occupational and Environmental Medicine, researchers tracked the status of more than  6,100 textile workers who had been employed at four Carolina textile mills that previously used asbestos in manufacturing. From the 1950s through the early 1970s, textile plants converted chrysotile asbestos, typically imported from Canada, and cotton fibers into yarn and woven materials. That created an occupational hazard of asbestos exposure for unsuspecting textile workers, who typically did not wear any breathing protection. 

The researchers, based at the University of Nebraska, Duke University and the University of North Carolina, reported a significantly elevated rate of death from lung cancer among the textile workers as compared to the general population. They determined that 3,356 of the textile workers employed in the mills had died as of 2003, and a disproportionate number had died of lung cancer, according to death certificate data.

The researchers also found a strong correlation between the increased mortality rate of lung cancer and the workers’ cumulative occupational exposure to asbestos. The cumulative exposure to asbestos varied considerably among the four plants. Exposure to asbestos usually occurs by breathing air in workplaces contaminated with microscopic asbestos fibers or swallowing asbestos fibers. Typically, workers do not experience symptoms of mesothelioma or other asbestos disease  for 20 years to 40 years after exposure to asbestos.

Another study published last year in the journal Lung Cancer found that textile workers in China who were exposed to asbestos had an increased risk of dying of lung cancer, mesothelioma and all forms of cancer. The trend was most pronounced among textile workers who had a high exposure to asbestos and also were smokers.

For more information about mesothelioma click here.

Early diagnosis of cancer generally leads to more effective treatment. So far, researchers have not identified any biomarkers with reasonable sensitivity and specificity to malignant mesothelioma, according to a 2012 study by German researchers published in the scientific journal PLoS One. Mesothelioma is an incurable cancer of the lining of the lung and abdomen associated with asbestos exposure. 

In the United States, doctors reported approximately 18,000 cases of malignant mesothelioma between 1999 and 2005. About 71,000 people in the U.S. are projected to be diagnosed with mesothelioma by 2054.

Reliable biomarkers for early diagnosis of mesothelioma need to be sensitive enough to detect tumors at early stages and specific enough to avoid false positives. Several groups of researchers have analyzed microRNA expression in malignant mesothelioma tissue samples. But the German researchers said the ideal biomarker would be one that could be observed by simply drawing a patient’s blood, a minimally-invasive procedure.

In the study, the researchers collected blood samples from 23 patients with malignant pleural mesothelioma ranging in age from 34 to 84 years old. The patients had yet to undergo surgery, chemotherapy or radiation to treat their disease.

The researchers found that the microRNA identified as miR-103 showed a promising sensitivity and specificity to malignant mesothelioma. It is part of a group of microRNAs associated with cell division, stress response and formation of new blood vessels, suggestion the deregulation of the microRNAs may contribute to human diseases. The presence of miR-103 was useful as a biomarker in distinguishing mesothelioma patients from cancer-free subjects in 75 percent to 80 percent of cases, they reported. The researchers said miR-103 should be investigated further as part of a panel of biomarkers in a prospective study.

Approximately, 2,500 to 3,000 people a year are diagnosed with mesothelioma in the U.S. Most are older workers, retirees and veterans who were exposed to asbestos decades ago, making diagnosis more difficult. The symptoms of mesothelioma typically take 20 years to 50 years to appear, so someone exposed to asbestos in the 1960s or 1970s may only recently have begun experiencing shortness of breath or other symptoms.

For more information about mesothelioma, click here.

According to a  Jan. 17 article in the Yorkshire Post,  eight adult children of Kora Leah, who was a foreman at Cape Asbestos in Hebben Bridge, Yorkshire, have been diagnosed with asbestos-related disease. The family has lost two siblings in recent months to mesothelioma.

When Marjorie King, one of Leah’s daughters died last July at age 67, a tumor was found on her right lung and asbestos particles were discovered in her lung tissue. Deputy Coroner Paul Marks concluded after an inquest that she died of mesothelioma.

Her sister, Maureen McGeogh, 73, of West Yorkshire, recalled that she and her siblings would play with their father when he returned home from work with his clothes still covered in asbestos dust. “I remember my mother shaking his overalls and dust going everywhere,” McGeogh recalled.

She said the children sometimes accompanied their father to work on Sunday and would play in the piles of dust. They were unaware of the danger of the asbestos dust.

Of the other siblings, Gerald, 78, has pleural plaques and emphysema while Cedric, 74, Rosalind, 71, Raymond, 69 and Glynn, 64, all have scarred lungs. Because of their exposure to asbestos they are at higher risk of developing mesothelioma.

The father Kora Leah died of lung cancer in 1958, 10 years after leaving Cape Asbestos, according to the newspaper.

According to the National Cancer Institute, there is evidence that family members of workers heavily exposed to asbestos face an increased risk of developing mesothelioma. The risk results from exposure to asbestos brought into the home on clothing, shoes, skin and hair.

When asbestos fibers get inhaled, they get trapped in the lung and remain there for a long time. The symptoms of mesothelioma typically appear 30 years to 50 years after initial exposure to asbestos. Possible signs of mesothelioma include shortness of breath and pain under the rib cage, pain or tightening of the chest, and a persistent cough that gets worse over time. It’s important to check with a doctor if you develop any of these symptoms and inform the doctor of any known exposure to asbestos.

For more information about mesothelioma, click here.

Mesothelioma is an aggressive cancer of the lining of the lung and abdomen that affects about 3,000 people in the U.S. each year. The mortality rate for mesothelioma is high, so more effective treatment options are needed to stop the progression of the disease.

The company’s lead product is a drug known as CBP501 that enhances the effectiveness of the chemotherapy drug Cisplatin, which is standard treatment for malignant pleural mesothelioma. CBP501, a synthetic peptide, enhances the toxicity of Cisplatin as it accumulates in mesothelioma tumors.

CanBas announced  in January  that the US FDA has granted orphan drug status to CBP501 for the treatment of malignant mesothelioma. The designation qualifies the pharmaceutical company for financial incentives for the development of drugs used to treat rare diseases. Without such incentives, drug companies have difficulty justifying the investment of time and resources necessary to bring to market drugs used to treat rare diseases that may have only a limited demand and therefore limited profit.

Currently, a randomized clinical trial is underway comparing the results of patients with advanced malignant pleural mesothelioma in the U.S., Russia and Argentina treated with the chemotherapy drugs Cisplatin/pemetrexed with and without the addition of CBP501.

Malignant mesothelioma symptoms usually don’t appear until decades after exposure to asbestos, typically 20 years to 50 years. Because mesothelioma is aggressive, doctors often do not diagnose a patient’s mesothelioma until the disease is well advanced.

For more information about mesothelioma, click here.

But researchers at the University of Pennsylvania hope the common cold virus may prove helpful in developing targeted treatments for people with early stage malignant mesothelioma. Msothelioma is an aggressive cancer of the lining of the lung and abdomen caused by exposure to asbestos.

In a recent study published in the American Journal of Respiratory and Critical Care Medicine, researchers at the University of Pennsylvania describe an immuno-gene therapy treatment that uses a modified common cold virus to trigger a patient’s immune system to destroy mesothelioma cells. Immunotherapy uses the body’s own defenses to fight cancer.

“Given our encouraging results in this trial with advanced stage patients, we believe that  (treatment) regimens incorporating immuno-gene therapy will have an important role in the treatment of earlier stage patients suffering from malignant mesothelioma,” said Dr. Steven M. Albelda, a professor of medicine at the Perelman School of Medicine and senior author of the study in a University of Pennsylvania press release.

The Penn researchers led by Dr. Albelda tested a new approach in which an adenovirus —a modified common cold virus—was altered in the laboratory to express high levels of a potent immune system stimulant called interferon-alpha.  Interferon-alpha is a protein produced by immune cells that boost the body’s ability to fight infections and some cancers.

Nine patients with varying stages of mesothelioma took part in a small clinical trial to test the new immuno-gene therapy treatment. Doctors injected the modified cold virus directly into the chest cavity of patients with malignant pleural mesothelioma. They noted antibody responses in nearly all the patients.

They observed evidence of tumor regression in five of the patients and no major side effects.

Mesothelioma is an aggressive cancer and often resistant to the standard treatments such as radiation and chemotherapy. Doctors are looking for more effective treatments for asbestos-related disease.

“Since there are very few effective treatments for advanced mesothelioma, it is important that we were able to demonstrate radiographic and biochemical evidence of clinical anti-tumor activity in some of our patients,” said Dr. Daniel Sterman, co-author of the study and co-director of the Penn Mesothelioma and Pleural Program.

Penn researchers are now testing the new approach in patients with early stage mesothelioma. It’s being used in combination with chemotherapy in a clinical trial sponsored by the National Cancer Institute.

Approximately 3,000 people are diagnosed with mesothelioma in the U.S. each year. Most are older workers, retired workers and veterans who were exposed to asbestos in a workplace. Family members of people who worked around asbestos also are at risk of developing the disease. Symptoms of mesothelioma typically appear 30 years to 50 years after exposure.

For more information about mesothelioma, click here.

In December 2010, Lee met with Clement Gignac, Quebec’s minister of natural resources and wildlife and called upon the minister to commit to stop subsidizing asbestos production in the province including the shuttered Jeffrey Mine.

Canada is a leading exporter of chrysotile asbestos, a mineral fiber that causes respiratory diseases including lung cancer and mesothelioma, a cancer of the lining of the lung and abdomen. According to the World Health Organization estimates, 107,000 people die each year of asbestos-related disease, including asbestosis, lung cancer and mesothelioma.

South Korea banned asbestos imports in 2009. But prior to that date, nearly two-thirds of the asbestos imported into South Korea came from Canada. Lee had lived close to a factory that produce cement products made of chrysotile asbestos.

During the 2010 visit, Lee spoke emotionally at a press conference at the Quebec National Assembly about the prospect of dying of asbestos disease and leaving her children as orphans and her husband as a widower. On Dec. 21, 2011, Lee died of mesothelioma, according to The Tyee, a Canadian online newspaper.

Following Lee’s death, anti-asbestos activists issued an open letter to the Quebec cabinet minister, reminding him of Lee’s dying wish and urging the provincial government to take a stand against the mining and export of asbestos. The government has not responded to the request, according to the newspaper.

In the U.S. approximately 3,000 people a year are diagnosed with mesothelioma. Most are older workers, retired workers and veterans who were expose to asbestos decades ago. Mesothelioma has a long latency period, with  symptoms of mesothelioma typically appearing 30 years to 50 years after exposure to asbestos.

For more information about mesothelioma, click here.

Mesothelioma is an aggressive cancer of the lining of the lungs and abdomen caused by asbestos exposure. But it can be difficult to detect as Moore’s circuitous path to a diagnosis shows.

Four years ago, Moore, who lives in Carl Junction, Missouri, was experiencing fatigue, an elevated heart rate and eventually pain in her right side that extended into her back. She assumed it was caused by the stress and physical exertion of caring for her husband Ed who had prostrate cancer.

According to an article in Cancerwise published by the M.D. Anderson Cancer Center, Moore underwent a series of medical tests that revealed a low hemoglobin count. A colonoscopy showed normal results as did a CT scan of her liver and pancreas. The doctor who performed a CT scan thought something looked abnormal about her lungs and referred her to a pulmonologist.

A pulmonary specialist did an x-ray and discovered a small volume of fluid in Moore’s lung and put her on antibiotics.  Fluid in the lungs, also called pleural effusions, is one of the common symptoms of mesothelioma reported by many patients. When Moore returned at the urging of the pulmonologist, she had another CT scan that revealed nearly two liters of fluid in her right lung. She underwent an outpatient procedure and biopsy that were inconclusive.

The cancer specialist to whom she was referred recommended an open lung biopsy. The surgeon who performed the procedure in November 2008 found 15 tumors in Moore’s right lung and diagnosed Moore with stage IV mesothelioma.

The doctor recommended that she seek treatment at M.D. Anderson Medical Center in Texas.

With patients with cancer limited to one lung, doctors may remove the cancerous lung and surrounding tissue and perform chemotherapy and radiation. But Moore had mesothelioma in both lungs so she had limited treatment options.

Moore underwent 28 chemotherapy treatments that lasted until December 2010. Before the treatments concluded, there was no active sign of mesothelioma. Moore’s physicican, Dr. Anne Tsao, director of the mesothelioma program at M.D. Anderson, informed Moore that she was the first of her patients to achieve full remission.

Approximately 3,000 people in the U.S. are diagnosed with mesothelioma each year. Many are older workers, veterans and retirees who were exposed to asbestos in the workplace decades ago. Typically, mesothelioma symptoms appear 30 years to 50 years after initial exposure to asbestos.

For more information about mesothelioma, click here.